PREMJI INVEST
P
urposE
P
hilosophy
P
artnerships
P
eople
P
erspectives
IN
US
India
Back to full portfolio
Molecular diagnostics platform, using proprietary technology to develop diagnostic tests for prenatal and oncology.
WEBSITE
Founder(s)/
promoter(s)
Oguzhan Atay, PhD and David Tsao, PhD
SECTOR(S)
No items found.
THEME(S)
Healthcare
Investment Stage
Growth
Company Status
Private
Perspectives
More about Billion To One
Perspectives
BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping
July 26, 2024
BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping
Perspectives
MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TEST
April 17, 2024
Billion to One
MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TEST
